Home NDC 68968-0210 XELSTRYM
Product NDC 68968-0210
11-digit product format 689680210
Labeler code 68968
Product ID 68968-0210_5ca2c95c-afcc-91a5-e063-6394a90a6663
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name DEXTROAMPHETAMINE
Dosage form PATCH, EXTENDED RELEASE
Route TRANSDERMAL
Labeler Noven Therapeutics, LLC
Application NDA215401
Marketing category NDA
Marketing start 2023-05-15
Substance DEXTROAMPHETAMINE
Active strength 9 mg/1
Pharmacologic classes Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]
DEA schedule CII
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N215401-001 XELSTRYM DEXTROAMPHETAMINE 4.5MG/9HR SYSTEM / TRANSDERMAL RLD 2022-03-22 N215401-002 XELSTRYM DEXTROAMPHETAMINE 9MG/9HR SYSTEM / TRANSDERMAL RLD 2022-03-22 N215401-003 XELSTRYM DEXTROAMPHETAMINE 13.5MG/9HR SYSTEM / TRANSDERMAL RLD 2022-03-22 N215401-004 XELSTRYM DEXTROAMPHETAMINE 18MG/9HR SYSTEM / TRANSDERMAL RLD, RS 2022-03-22
Orange Book patents# Current patent rows page 1 of 1 · 16 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N215401-001 9456993 2033-10-24 U-3340 Drug product 2022-04-14 N215401-001 9474722 2033-10-24 Drug product 2022-04-14 N215401-001 12678504 2034-03-12 U-4583 Drug product 2026-08-10 N215401-001 11559501 2042-01-06 Drug product 2023-02-17 N215401-002 9456993 2033-10-24 U-3340 Drug product 2022-04-14 N215401-002 9474722 2033-10-24 Drug product 2022-04-14 N215401-002 12678504 2034-03-12 U-4583 Drug product 2026-08-10 N215401-002 11559501 2042-01-06 Drug product 2023-02-17 N215401-003 9456993 2033-10-24 U-3340 Drug product 2022-04-14 N215401-003 9474722 2033-10-24 Drug product 2022-04-14 N215401-003 12678504 2034-03-12 U-4583 Drug product 2026-08-10 N215401-003 11559501 2042-01-06 Drug product 2023-02-17 N215401-004 9456993 2033-10-24 U-3340 Drug product 2022-04-14 N215401-004 9474722 2033-10-24 Drug product 2022-04-14 N215401-004 12678504 2034-03-12 U-4583 Drug product 2026-08-10 N215401-004 11559501 2042-01-06 Drug product 2023-02-17
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 132 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-10-15 13:18:30 2026-09 N215401-001 XELSTRYM 4.5MG/9HR SYSTEM / TRANSDERMAL RLD 2022-03-22 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215401-002 XELSTRYM 9MG/9HR SYSTEM / TRANSDERMAL RLD 2022-03-22 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215401-003 XELSTRYM 13.5MG/9HR SYSTEM / TRANSDERMAL RLD 2022-03-22 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215401-004 XELSTRYM 18MG/9HR SYSTEM / TRANSDERMAL RLD, RS 2022-03-22 c2088c7a36db…2026-09-14 22:38:34 2026-08 N215401-001 XELSTRYM 4.5MG/9HR SYSTEM / TRANSDERMAL RLD 2022-03-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 N215401-002 XELSTRYM 9MG/9HR SYSTEM / TRANSDERMAL RLD 2022-03-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 N215401-003 XELSTRYM 13.5MG/9HR SYSTEM / TRANSDERMAL RLD 2022-03-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 N215401-004 XELSTRYM 18MG/9HR SYSTEM / TRANSDERMAL RLD, RS 2022-03-22 84e616aacf4f…2026-08-18 06:07:40 2026-07 N215401-001 XELSTRYM 4.5MG/9HR SYSTEM / TRANSDERMAL RLD 2022-03-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N215401-002 XELSTRYM 9MG/9HR SYSTEM / TRANSDERMAL RLD 2022-03-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N215401-003 XELSTRYM 13.5MG/9HR SYSTEM / TRANSDERMAL RLD 2022-03-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N215401-004 XELSTRYM 18MG/9HR SYSTEM / TRANSDERMAL RLD, RS 2022-03-22 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N215401-001 XELSTRYM 4.5MG/9HR SYSTEM / TRANSDERMAL RLD 2022-03-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215401-002 XELSTRYM 9MG/9HR SYSTEM / TRANSDERMAL RLD 2022-03-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215401-003 XELSTRYM 13.5MG/9HR SYSTEM / TRANSDERMAL RLD 2022-03-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N215401-004 XELSTRYM 18MG/9HR SYSTEM / TRANSDERMAL RLD, RS 2022-03-22 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215401-001 XELSTRYM 4.5MG/9HR SYSTEM / TRANSDERMAL RLD 2022-03-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215401-002 XELSTRYM 9MG/9HR SYSTEM / TRANSDERMAL RLD 2022-03-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215401-003 XELSTRYM 13.5MG/9HR SYSTEM / TRANSDERMAL RLD 2022-03-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N215401-004 XELSTRYM 18MG/9HR SYSTEM / TRANSDERMAL RLD, RS 2022-03-22 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N215401-001 XELSTRYM 4.5MG/9HR SYSTEM / TRANSDERMAL RLD 2022-03-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N215401-002 XELSTRYM 9MG/9HR SYSTEM / TRANSDERMAL RLD 2022-03-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N215401-003 XELSTRYM 13.5MG/9HR SYSTEM / TRANSDERMAL RLD 2022-03-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N215401-004 XELSTRYM 18MG/9HR SYSTEM / TRANSDERMAL RLD, RS 2022-03-22 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N215401-001 XELSTRYM 4.5MG/9HR SYSTEM / TRANSDERMAL RLD 2022-03-22 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N215401-002 XELSTRYM 9MG/9HR SYSTEM / TRANSDERMAL RLD 2022-03-22 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N215401-003 XELSTRYM 13.5MG/9HR SYSTEM / TRANSDERMAL RLD 2022-03-22 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N215401-004 XELSTRYM 18MG/9HR SYSTEM / TRANSDERMAL RLD, RS 2022-03-22 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N215401-001 XELSTRYM 4.5MG/9HR SYSTEM / TRANSDERMAL RLD 2022-03-22 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N215401-002 XELSTRYM 9MG/9HR SYSTEM / TRANSDERMAL RLD 2022-03-22 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N215401-003 XELSTRYM 13.5MG/9HR SYSTEM / TRANSDERMAL RLD 2022-03-22 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N215401-004 XELSTRYM 18MG/9HR SYSTEM / TRANSDERMAL RLD, RS 2022-03-22 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N215401-001 XELSTRYM 4.5MG/9HR SYSTEM / TRANSDERMAL RLD 2022-03-22 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N215401-002 XELSTRYM 9MG/9HR SYSTEM / TRANSDERMAL RLD 2022-03-22 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N215401-003 XELSTRYM 13.5MG/9HR SYSTEM / TRANSDERMAL RLD 2022-03-22 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N215401-004 XELSTRYM 18MG/9HR SYSTEM / TRANSDERMAL RLD, RS 2022-03-22 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N215401-001 XELSTRYM 4.5MG/9HR SYSTEM / TRANSDERMAL RLD 2022-03-22 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N215401-002 XELSTRYM 9MG/9HR SYSTEM / TRANSDERMAL RLD 2022-03-22 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N215401-003 XELSTRYM 13.5MG/9HR SYSTEM / TRANSDERMAL RLD 2022-03-22 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N215401-004 XELSTRYM 18MG/9HR SYSTEM / TRANSDERMAL RLD, RS 2022-03-22 2680178bc6a6…
Observed Orange Book patent history# Patent history page 1 of 18 · 696 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-10-15 13:18:30 2026-09 N215401-001 9456993 2033-10-24 U-3340 Drug product 2022-04-14 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215401-001 9474722 2033-10-24 Drug product 2022-04-14 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215401-001 12678504 2034-03-12 U-4583 Drug product 2026-08-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215401-001 11559501 2042-01-06 Drug product 2023-02-17 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215401-002 9456993 2033-10-24 U-3340 Drug product 2022-04-14 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215401-002 9474722 2033-10-24 Drug product 2022-04-14 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215401-002 12678504 2034-03-12 U-4583 Drug product 2026-08-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215401-002 11559501 2042-01-06 Drug product 2023-02-17 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215401-003 9456993 2033-10-24 U-3340 Drug product 2022-04-14 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215401-003 9474722 2033-10-24 Drug product 2022-04-14 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215401-003 12678504 2034-03-12 U-4583 Drug product 2026-08-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215401-003 11559501 2042-01-06 Drug product 2023-02-17 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215401-004 9456993 2033-10-24 U-3340 Drug product 2022-04-14 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215401-004 9474722 2033-10-24 Drug product 2022-04-14 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215401-004 12678504 2034-03-12 U-4583 Drug product 2026-08-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N215401-004 11559501 2042-01-06 Drug product 2023-02-17 c2088c7a36db…2026-09-14 22:38:34 2026-08 N215401-001 9456993 2033-10-24 U-3340 Drug product 2022-04-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N215401-001 9474722 2033-10-24 Drug product 2022-04-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N215401-001 12678504 2034-03-12 U-4583 Drug product 2026-08-10 84e616aacf4f…2026-09-14 22:38:34 2026-08 N215401-001 11559501 2042-01-06 Drug product 2023-02-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N215401-002 9456993 2033-10-24 U-3340 Drug product 2022-04-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N215401-002 9474722 2033-10-24 Drug product 2022-04-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N215401-002 12678504 2034-03-12 U-4583 Drug product 2026-08-10 84e616aacf4f…2026-09-14 22:38:34 2026-08 N215401-002 11559501 2042-01-06 Drug product 2023-02-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N215401-003 9456993 2033-10-24 U-3340 Drug product 2022-04-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N215401-003 9474722 2033-10-24 Drug product 2022-04-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N215401-003 12678504 2034-03-12 U-4583 Drug product 2026-08-10 84e616aacf4f…2026-09-14 22:38:34 2026-08 N215401-003 11559501 2042-01-06 Drug product 2023-02-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N215401-004 9456993 2033-10-24 U-3340 Drug product 2022-04-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N215401-004 9474722 2033-10-24 Drug product 2022-04-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N215401-004 12678504 2034-03-12 U-4583 Drug product 2026-08-10 84e616aacf4f…2026-09-14 22:38:34 2026-08 N215401-004 11559501 2042-01-06 Drug product 2023-02-17 84e616aacf4f…2026-08-18 06:07:40 2026-07 N215401-001 9456993 2033-10-24 U-3340 Drug product 2022-04-14 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N215401-001 9474722 2033-10-24 Drug product 2022-04-14 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N215401-001 12678504 2034-03-12 U-4583 Drug product 2026-08-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N215401-001 11559501 2042-01-06 Drug product 2023-02-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N215401-002 9456993 2033-10-24 U-3340 Drug product 2022-04-14 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N215401-002 9474722 2033-10-24 Drug product 2022-04-14 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N215401-002 12678504 2034-03-12 U-4583 Drug product 2026-08-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N215401-002 11559501 2042-01-06 Drug product 2023-02-17 caaa826d4ba7…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 3 · 108 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base XELSTRYM
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength DEXTROAMPHETAMINE 9 mg/1
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 68968-0210-1 XELSTRYM 1 in 1 POUCH PATCH, EXTENDED RELEASE 1 17 68968-0210-3 XELSTRYM 30 in 1 CARTON PATCH, EXTENDED RELEASE 30 17
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 68968-0210 XELSTRYM (DEXTROAMPHETAMINE) PATCH, EXTENDED RELEASE [NOVEN THERAPEUTICS, LLC] 14 Current NDC, Legacy NDC, 2 package rows 20241222_0862f02a-72a8-41cc-8845-57cf4974bb6f.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 68968-0210-1 68968021001 1 in 1 POUCH Historical 68968-0210-3 68968021003 30 POUCH in 1 CARTON (68968-0210-3) / 1 PATCH, EXTENDED RELEASE in 1 POUCH (68968-0210-1) 30 pouch 2023-05-15 0000-00-00 No No Current